Sanofi SA (LTS:0A2V)
$ 49 0 (0%) Market Cap: 122.85 Bil Enterprise Value: 141.18 Bil PE Ratio: 28.19 PB Ratio: 1.63 GF Score: 87/100

Sanofi SA at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 15, 2020 / 06:45PM GMT
Release Date Price: $51.69
Mark Douglas Purcell
Morgan Stanley, Research Division - Equity Analyst

Well, good afternoon, and good evening, everyone. This is Mark Purcell from the Morgan Stanley European biopharma team. It gives me great pleasure to be introducing Sanofi today.

Before I introduce the speakers, there is some disclaimers I need to read out. So please note that this webcast is for Morgan Stanley's clients and appropriate Morgan Stanley employees only. This webcast is not for members of the press. And if you are a member of the press, please disconnect and reach out separately. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclaimers. So if you have any questions, please reach out to your Morgan Stanley sales representatives.

But I'm going to hand over to you guys at Sanofi and our Q&A.

So we're in a very lucky position. We have 2 people today. Dietmar Berger, who's the Global Head of Clinical Development and the Chief Medical

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot